Aim Using a high‐flow nasal cannula (HFNC) for infant bronchiolitis is increasingly common,
but insufficiently studied. In this retrospective study, we examined the outcomes of HFNC …

Background The objective was to determine whether high-flow nasal cannula (HFNC), a
promising respiratory support in infant bronchiolitis, could reduce the proportion of treatment …

Aim To obtain data on the safety and clinical impact of managing infants with bronchiolitis on
the ward with high‐flow nasal cannula (HFNC) treatment. Methods A prospective pilot study …

The American Academy of Pediatrics (AAP) guidelines recommend only supportive therapy
for hospitalised infants with viral bronchiolitis. This includes oxygen therapy for hypoxaemia …

Aim We aimed to describe the characteristics and outcomes of infants with bronchiolitis who
received high‐flow nasal cannula oxygen (HFNC) following a two‐tiered approach. Methods …

High-flow nasal cannula (HFNC) is a widely used ventilatory support in children with
bronchiolitis in the intensive care setting. No data is available on HFNC use in the general …

Aim Bronchiolitis is a common condition in the paediatric population. Severe cases often
receive respiratory support with high‐flow nasal cannula (HFNC). Significant variation in the …

Background This study aimed to assess how the emergence of high-flow nasal cannula
(HFNC) has modified the demographic and clinical characteristics as well as outcomes of …

Aim An observational study was carried out on infants with moderate to severe bronchiolitis
to compare the clinical outcomes following treatment with a high‐flow nasal cannula (HFNC) …

Aim To determine the prevalence of high flow nasal cannula (HFNC) therapy in infants
presenting to hospital in Australia and New Zealand with bronchiolitis over four bronchiolitis …